293 related articles for article (PubMed ID: 17697008)
1. Identification of TSH receptor mutations in three families with resistance to TSH.
Tonacchera M; Di Cosmo C; De Marco G; Agretti P; Banco M; Perri A; Gianetti E; Montanelli L; Vitti P; Pinchera A
Clin Endocrinol (Oxf); 2007 Nov; 67(5):712-8. PubMed ID: 17697008
[TBL] [Abstract][Full Text] [Related]
2. Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance.
Calebiro D; de Filippis T; Lucchi S; Covino C; Panigone S; Beck-Peccoz P; Dunlap D; Persani L
Hum Mol Genet; 2005 Oct; 14(20):2991-3002. PubMed ID: 16135555
[TBL] [Abstract][Full Text] [Related]
3. Low prevalence of thyrotropin receptor mutations in a large series of subjects with sporadic and familial nonautoimmune subclinical hypothyroidism.
Tonacchera M; Perri A; De Marco G; Agretti P; Banco ME; Di Cosmo C; Grasso L; Vitti P; Chiovato L; Pinchera A
J Clin Endocrinol Metab; 2004 Nov; 89(11):5787-93. PubMed ID: 15531543
[TBL] [Abstract][Full Text] [Related]
4. Functional studies of new TSH receptor (TSHr) mutations identified in patients affected by hypothyroidism or isolated hyperthyrotrophinaemia.
De Marco G; Agretti P; Camilot M; Teofoli F; Tatò L; Vitti P; Pinchera A; Tonacchera M
Clin Endocrinol (Oxf); 2009 Feb; 70(2):335-8. PubMed ID: 18727713
[TBL] [Abstract][Full Text] [Related]
5. Thyrotropin receptor gene mutations and TSH resistance: variable expressivity in the heterozygotes.
Camilot M; Teofoli F; Gandini A; Franceschi R; Rapa A; Corrias A; Bona G; Radetti G; Tatò L
Clin Endocrinol (Oxf); 2005 Aug; 63(2):146-51. PubMed ID: 16060907
[TBL] [Abstract][Full Text] [Related]
6. Congenital hypothyroidism with impaired thyroid response to thyrotropin (TSH) and absent circulating thyroglobulin: evidence for a new inactivating mutation of the TSH receptor gene.
Tonacchera M; Agretti P; Pinchera A; Rosellini V; Perri A; Collecchi P; Vitti P; Chiovato L
J Clin Endocrinol Metab; 2000 Mar; 85(3):1001-8. PubMed ID: 10720030
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the mouse TSH receptor equivalent to human constitutively activating TSH receptor mutations also cause constitutive activity.
Neumann S; Krohn K; Chey S; Paschke R
Horm Metab Res; 2001 May; 33(5):263-9. PubMed ID: 11440271
[TBL] [Abstract][Full Text] [Related]
8. Identification and functional analysis of novel inactivating thyrotropin receptor mutations in patients with thyrotropin resistance.
Tsunekawa K; Onigata K; Morimura T; Kasahara T; Nishiyama S; Kamoda T; Mori M; Morikawa A; Murakami M
Thyroid; 2006 May; 16(5):471-9. PubMed ID: 16756469
[TBL] [Abstract][Full Text] [Related]
9. Germline mutations of TSH receptor gene as cause of nonautoimmune subclinical hypothyroidism.
Alberti L; Proverbio MC; Costagliola S; Romoli R; Boldrighini B; Vigone MC; Weber G; Chiumello G; Beck-Peccoz P; Persani L
J Clin Endocrinol Metab; 2002 Jun; 87(6):2549-55. PubMed ID: 12050212
[TBL] [Abstract][Full Text] [Related]
10. Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland.
Abramowicz MJ; Duprez L; Parma J; Vassart G; Heinrichs C
J Clin Invest; 1997 Jun; 99(12):3018-24. PubMed ID: 9185526
[TBL] [Abstract][Full Text] [Related]
11. Prolonged inappropriate TSH suppression during hypothyroidism after thyroid ablation in a patient with nonautoimmune familial hyperthyroidism.
Jaeschke H; Eszlinger M; Lueblinghoff J; Coslovsky R; Paschke R
Horm Metab Res; 2011 Jun; 43(7):500-4. PubMed ID: 21590647
[TBL] [Abstract][Full Text] [Related]
12. A family with congenital hypothyroidism caused by a combination of loss-of-function mutations in the thyrotropin receptor and adenylate cyclase-stimulating G alpha-protein subunit genes.
Lado-Abeal J; Castro-Piedras I; Palos-Paz F; Labarta-Aizpún JI; Albero-Gamboa R
Thyroid; 2011 Feb; 21(2):103-9. PubMed ID: 21186955
[TBL] [Abstract][Full Text] [Related]
13. Constitutive activation of the thyrotropin receptor by deletion of a portion of the extracellular domain.
Zhang ML; Sugawa H; Kosugi S; Mori T
Biochem Biophys Res Commun; 1995 Jun; 211(1):205-10. PubMed ID: 7779086
[TBL] [Abstract][Full Text] [Related]
14. A familial thyrotropin (TSH) receptor mutation provides in vivo evidence that the inositol phosphates/Ca2+ cascade mediates TSH action on thyroid hormone synthesis.
Grasberger H; Van Sande J; Hag-Dahood Mahameed A; Tenenbaum-Rakover Y; Refetoff S
J Clin Endocrinol Metab; 2007 Jul; 92(7):2816-20. PubMed ID: 17456567
[TBL] [Abstract][Full Text] [Related]
15. Mutations of thyrotropin receptor isolated from thyroid autonomous functioning adenomas confer TSH-independent growth to thyroid cells.
Porcellini A; Ruggiano G; Pannain S; Ciullo I; Amabile G; Fenzi G; Avvedimento EV
Oncogene; 1997 Aug; 15(7):781-9. PubMed ID: 9266964
[TBL] [Abstract][Full Text] [Related]
16. Lack of in vitro constitutive activity for four previously reported TSH receptor mutations identified in patients with nonautoimmune hyperthyroidism and hot thyroid carcinomas.
Jaeschke H; Mueller S; Eszlinger M; Paschke R
Clin Endocrinol (Oxf); 2010 Dec; 73(6):815-20. PubMed ID: 20846293
[TBL] [Abstract][Full Text] [Related]
17. A novel mutation (M310L) in the thyroid hormone receptor beta causing resistance to thyroid hormone in a Brazilian kindred and a neonate.
Furlanetto TW; Kopp P; Peccin S; Gu WX; Jameson JL
Mol Genet Metab; 2000 Nov; 71(3):520-6. PubMed ID: 11073720
[TBL] [Abstract][Full Text] [Related]
18. Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia.
Tonacchera M; Van Sande J; Cetani F; Swillens S; Schvartz C; Winiszewski P; Portmann L; Dumont JE; Vassart G; Parma J
J Clin Endocrinol Metab; 1996 Feb; 81(2):547-54. PubMed ID: 8636266
[TBL] [Abstract][Full Text] [Related]
19. Identification and functional characterization of two novel activating thyrotropin receptor mutants in toxic thyroid follicular adenomas.
Castro I; Lima L; Seoane R; Lado-Abeal J
Thyroid; 2009 Jun; 19(6):645-9. PubMed ID: 19499991
[TBL] [Abstract][Full Text] [Related]
20. Thyroid disruptor 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT) prevents internalization of TSH receptor.
Picchietti S; Belardinelli M; Taddei AR; Fausto AM; Pellegrino M; Maggio R; Rossi M; Giorgi F
Cell Tissue Res; 2009 Apr; 336(1):31-40. PubMed ID: 19214582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
